Urticarial Vasculitis Associated with Dabigatran

Authors

  • Elisa Macedo Brás Internal Medicine Service. Unidade Local de Saúde de Trás-os-Montes e Alto Douro. Vila Real. Portugal.
  • Raquel Costeira Internal Medicine Service. Unidade Local de Saúde de Trás-os-Montes e Alto Douro. Vila Real. Portugal.
  • Anusca Paixão Internal Medicine Service. Unidade Local de Saúde de Trás-os-Montes e Alto Douro. Vila Real. Portugal.
  • Nuno Ferreira da Silva Internal Medicine Service. Unidade Local de Saúde de Trás-os-Montes e Alto Douro. Vila Real. Portugal.

DOI:

https://doi.org/10.20344/amp.21921

Keywords:

Dabigatran/adverse effects, Vasculitis/etiology

Downloads

Download data is not yet available.

References

Kolkhir P, Grakhova M, Bonnekoh H, Krause K, Maurer M. Treatment of urticarial vasculitis: a systematic review. J Allergy Clin Immunol. 2019;143:458-66.

Mohamoud M, Horgan C, Eworuke E, Dee E, Bohn J, Shapira O, et al. Complementary use of U.S. FDA’s adverse event reporting system and sentinela system to characterize direct oral anticoagulants-associated cutaneous small vessel vasculitis. Pharmacotherapy. 2020;40:1099-107.

Vu TT, Gooderham M. Adverse drug reactions and cutaneous manifestations associated with anticoagulation. J Cutan Med Surg. 2017;21:540-50.

An J, Garje R, Wanat KA, Leone JP. Dabigatran-related leukocytoclastic vasculitis. BMJ Case Rep. 2017:bcr2016217423.

Sander R. Dabigatran versus warfarin in patients with atrial fibrillation. Nurs Older People. 2017;29:11.

Downloads

Published

2024-10-30

How to Cite

1.
Macedo Brás E, Costeira R, Paixão A, Ferreira da Silva N. Urticarial Vasculitis Associated with Dabigatran. Acta Med Port [Internet]. 2024 Oct. 30 [cited 2024 Nov. 7];. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/21921

Issue

Section

Letters to the Editor